Posts Tagged: Omar Khan
A recent study led by researchers at the University of Toronto sheds new light on a crucial challenge in the field of nucleic acid drug delivery: how to make lipid nanoparticles (LNPs) break down more quickly in the body. This discovery could pave the way for medicines that can be administered more frequently and with fewer side effects.
Six graduate students from the Institute of Biomedical Engineering (BME) at the University of Toronto have been awarded a combined funding of over $462,000 over three years through the Natural Science and Engineering Research Councils of Canada (NSERC).
Professor Omar F. Khan has been awarded the prestigious McCharles Prize for Early Career Research Distinction for his contributions to the fields of biomedical and immune engineering.
Meet Danielle Serra and Janice Pang, two exceptional individuals seamlessly balancing the demands of academia and their passion for curling. In this profile Q&A, the duo shares their unique journeys into the world of curling, from a chance encounter at a university event to becoming members of the University Varsity Curling team.
Meet Ana-Maria, a PhD student in Dr. Omar Khan’s lab. Ana-Maria's journey seamlessly weaves together her love for art, her dedication to advancing scientific frontiers, and her commitment to breaking barriers in the medical field.
Back in 2021, one year into the lockdown, we sat down with 6 MASc and PhD students from BME, exploring their visions for a world changed in two years’ time. Recently, we had the opportunity to reconnect with these extraordinary individuals and witness the profound evolution of their perspectives.
U of T Engineering lab partners with Moderna to develop RNA-based tools to treat and prevent disease
A team of U of T Engineering researchers, led by Professor Omar F. Khan (BME), has partnered with biotechnology company Moderna to develop next-generation RNA platform technologies.
Dr. Omar Khan is one of four researchers are the latest to receive support to spin-off aspects of their Medicine by Design-funded research into an early-stage product or venture as part of Medicine by Design’s Pivotal Experiment Fund, which has distributed more than $2.5-million in funding since its launch in early 2021.
Azane Therapeutics, made up of members from the Omar F. Khan lab, was the second-place team at the Building a Biotech Venture Pitch Competition.
Omar F. Khan was first inspired to be an engineer by his father's workplace accident. Now, his lab is studying nanomaterials & pushing the boundaries of regenerative medicine.
Showing 1 - 10 of 20 results